Cargando…

Therapeutic Potentials of Low-Dose Tacrolimus for Aberrant Endometrial Features in Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is a major anovulatory infertility affecting a great proportion of women of childbearing age and is associated with obesity, insulin resistance and chronic inflammation. Poor endometrial receptivity and recurrent implantation failure are major hurdles to the establis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albaghdadi, Ahmad J. H., Kan, Frederick W. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998611/ https://www.ncbi.nlm.nih.gov/pubmed/33808965 http://dx.doi.org/10.3390/ijms22062872

Ejemplares similares

Low-Dose Tacrolimus Prevents Dysregulated Peri-Conceptional Ovarian and Systemic Immune Cellular Homeostasis in Subjects with PCOS
por: Albaghdadi, Ahmad J. H., et al.
Publicado: (2019)

Low-Dose Tacrolimus Promotes the Migration and Invasion and Nitric Oxide Production in the Human-Derived First Trimester Extravillous Trophoblast Cells In Vitro
por: Albaghdadi, Ahmad J. H., et al.
Publicado: (2022)

Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice
por: Ryu, Youngjae, et al.
Publicado: (2021)

Lipidomic Biomarkers in Polycystic Ovary Syndrome and Endometrial Cancer
por: Shafiee, Mohamad Nasir, et al.
Publicado: (2020)

Features of Polycystic Ovary Syndrome in adolescence
por: Tsikouras, P, et al.
Publicado: (2015)

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome
por: Shan, Hongying, et al.
Publicado: (2022)

Endometrial histology and predictable clinical factors for endometrial disease in women with polycystic ovary syndrome
por: Park, Joon Cheol, et al.
Publicado: (2011)

Tacrolimus in the prevention of adverse pregnancy outcomes and diabetes-associated embryopathies in obese and diabetic mice
por: Albaghdadi, Ahmad J. H., et al.
Publicado: (2017)

Polycystic ovary syndrome: pathophysiology and therapeutic opportunities
por: Dong, Jiawen, et al.
Publicado: (2023)

Proteomic alteration of endometrial tissues during secretion in polycystic ovary syndrome may affect endometrial receptivity
por: Li, Jun, et al.
Publicado: (2022)

Delayed endometrial decidualisation in polycystic ovary syndrome; the role of AR-MAGEA11
por: Younas, Kinza, et al.
Publicado: (2019)

Women with polycystic ovary syndrome present with altered endometrial expression of stanniocalcin-1(†)
por: Khatun, Masuma, et al.
Publicado: (2020)

The Lifestyle Modifications and Endometrial Proteome Changes of Women With Polycystic Ovary Syndrome and Obesity
por: Abdulkhalikova, D., et al.
Publicado: (2022)

SAT370 Economic Burden of Endometrial Cancer Associated with Polycystic Ovary Syndrome
por: Pace, Lauren Arielle, et al.
Publicado: (2023)

Clinical and metabolic characteristics of endometrial lesions in polycystic ovary syndrome at reproductive age
por: Zhong⋅, Xiaozhu, et al.
Publicado: (2023)

Potentials of curcumin against polycystic ovary syndrome: Pharmacological insights and therapeutic promises
por: Akter, Tanzina, et al.
Publicado: (2023)

Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols
por: Sortino, Maria A., et al.
Publicado: (2017)

An update of polycystic ovary syndrome: causes and therapeutics options
por: Rababa’h, Abeer M., et al.
Publicado: (2022)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review
por: Harris, Holly R., et al.
Publicado: (2016)

Research progress of endometrial receptivity in patients with polycystic ovary syndrome: a systematic review
por: Bai, Xuechun, et al.
Publicado: (2021)

Polycystic Ovary Syndrome and Endometrial Cancer: A Scoping Review of the Literature on Gut Microbiota
por: Prakash, Amog, et al.
Publicado: (2022)

Antimüllerian hormone and endometrial thickness in predicting xfollicular maturation in patients with polycystic ovary syndrome
por: Omer, Alaa Abdelaal Hassan, et al.
Publicado: (2023)

The physiological functions and therapeutic potential of exosomes during the development and treatment of polycystic ovary syndrome
por: Zhang, Zhenghong, et al.
Publicado: (2023)

Ultra-low Doses of Follicle Stimulating Hormone and Progesterone Attenuate the Severity of Polycystic Ovary Syndrome Features in a Hyperandrogenized Mouse Model
por: Tessaro, Irene, et al.
Publicado: (2017)

Aberrant activation of the Hedgehog signaling pathway in granulosa cells from patients with polycystic ovary syndrome
por: Li, You, et al.
Publicado: (2021)

Screening and validation of potential markers associated with uterine corpus endometrial carcinoma and polycystic ovary syndrome based on bioinformatics methods
por: Wu, Ruishan, et al.
Publicado: (2023)

Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
por: Singh, Samradhi, et al.
Publicado: (2023)

Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
por: Wang, Kexin, et al.
Publicado: (2023)

Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects
por: Mastnak, Lara, et al.
Publicado: (2023)

Potential genetic polymorphisms predicting polycystic ovary syndrome
por: Chen, Yao, et al.
Publicado: (2018)

The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
por: Anala, Alekya Devi, et al.
Publicado: (2023)

Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents
por: Calcaterra, Valeria, et al.
Publicado: (2023)

Endometrial tuberculosis compounding polycystic ovary syndrome in a subfertile woman: a case report
por: Mariara, Charles, et al.
Publicado: (2016)

Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
por: Ignatov, Atanas, et al.
Publicado: (2020)

Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome
por: Wang, Lulu, et al.
Publicado: (2021)

Decreased Endometrial Thickness Is Associated With Higher Risk of Neonatal Complications in Women With Polycystic Ovary Syndrome
por: Huang, Jialyu, et al.
Publicado: (2021)

The Genetic Association of Polycystic Ovary Syndrome and the Risk of Endometrial Cancer: A Mendelian Randomization Study
por: Chen, Hanxiao, et al.
Publicado: (2021)

Transcriptomic Analysis Reveals Endometrial Dynamics in Normoweight and Overweight/Obese Polycystic Ovary Syndrome Women
por: Liu, Su, et al.
Publicado: (2022)

The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents
por: Khashchenko, Elena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n200j6rfs1de587cbo49cf46a0